Target Name: REXO1L1P
NCBI ID: G254958
Review Report on REXO1L1P Target / Biomarker Content of Review Report on REXO1L1P Target / Biomarker
REXO1L1P
Other Name(s): REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1 | RNA exonuclease 1 homolog-like 1 | Putative exonuclease GOR | REXO1 like 1, pseudogene | Antigen GOR homolog | REXO1L1 | GOR antigen | GOR | Exonuclease GOR | GOR_HUMAN

REXO1L1P: A Potential Drug Target and Biomarker for RNA Exonuclease 1 Homolog in S. cerevisiae

Abstract:

RNA exonuclease 1 (RNA-1) is a key enzyme involved in the process of post-transcriptional modification of RNA, which plays a crucial role in various cellular processes, including gene regulation, translation, and DNA replication. The gene encoding RNA-1 , also known as REXO1L1P (REX1, RNA exonuclease 1 homolog), has been identified as a potential drug target and biomarker in the study of S. cerevisiae. This article will provide an overview of the biology of RNA-1 and its role in cellular processes, as well as the potential implications of targeting REXO1L1P as a drug or biomarker.

Introduction:

RNA-1 is a transmembrane protein that functions as the primary executor of the exonuclease 1 (RNA-1) enzyme, which is responsible for the cleavage of RNA by specific endonuclease. This enzyme plays a crucial role in post- transcriptional modification of RNA, including the removal of non-coding RNA (ncRNA), the addition of ribose units, and the modification of the RNA secondary structure.

Relevance of RNA-1 in Cellular Processes:

RNA-1 is involved in various cellular processes, including gene regulation, translation, DNA replication, and RNA homeostasis. In gene regulation, RNA-1 is involved in the regulation of gene expression by RNA polymerase II (RNA-II), which is the enzyme responsible for producing functional RNA from genomic DNA. Additionally, RNA-1 is involved in the regulation of gene promoter accessibility, which is critical for the expression of various genes.

In translation, RNA-1 is involved in the recognition of exonic RNA by the ribosome, which is the protein complex responsible for producing functional proteins from RNA templates. Furthermore, RNA-1 is involved in the regulation of protein stability and localization, which is critical for the proper functioning of various cellular processes.

In DNA replication, RNA-1 is involved in the regulation of DNA replication by RNA polymerase I (RNA-I), which is responsible for producing a double-stranded DNA copy from a single-stranded DNA template.

Potential Implications of Targeting REXO1L1P:

The potential drug target and biomarker properties of REXO1L1P make it an attractive target for drug development. If targeting REXO1L1P were successful, it could have a variety of therapeutic implications, including the treatment of various diseases.

First, targeting REXO1L1P could potentially be used to treat diseases caused by the overproduction of RNA-1, such as cancer, where the production of functional RNA is disrupted. Second, targeting REXO1L1P could potentially be used to treat diseases caused by the underproduction of RNA -1, such as neurodegenerative diseases, where the production of functional RNA is excessive.

Furthermore, targeting REXO1L1P could potentially be used to treat diseases caused by the misregulation of RNA-1, such as diseases caused by RNA-1 being produced at the expense of other RNA molecules.

Conclusion:

In conclusion, the biology of RNA-1 and its role in cellular processes have been reviewed, with a focus on its involvement in post-transcriptional modification of RNA. The potential drug target and biomarker properties of REXO1L1P have been discussed, as well as its potential therapeutic implications in diseases caused by the overproduction or underproduction of RNA-1. Further research is needed to

Protein Name: REXO1 Like 1, Pseudogene

The "REXO1L1P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about REXO1L1P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

REXO1L2P | REXO1L6P | REXO1L8P | REXO2 | REXO4 | REXO5 | RFC1 | RFC2 | RFC3 | RFC4 | RFC5 | RFESD | RFESDP1 | RFFL | RFK | RFLNA | RFLNB | RFNG | RFPL1 | RFPL1S | RFPL2 | RFPL3 | RFPL3S | RFPL4A | RFPL4AL1 | RFPL4B | RFT1 | RFTN1 | RFTN2 | RFWD3 | RFX complex | RFX1 | RFX2 | RFX3 | RFX3-DT | RFX4 | RFX5 | RFX5-AS1 | RFX6 | RFX7 | RFX8 | RFXANK | RFXAP | RGCC | RGL1 | RGL2 | RGL3 | RGL4 | RGMA | RGMB | RGMB-AS1 | RGN | RGP1 | RGPD1 | RGPD2 | RGPD3 | RGPD4 | RGPD4-AS1 | RGPD5 | RGPD6 | RGPD8 | RGR | RGS1 | RGS10 | RGS11 | RGS12 | RGS13 | RGS14 | RGS16 | RGS17 | RGS18 | RGS19 | RGS2 | RGS20 | RGS21 | RGS22 | RGS3 | RGS4 | RGS5 | RGS6 | RGS7 | RGS7BP | RGS8 | RGS9 | RGS9BP | RGSL1 | RHAG | RHBDD1 | RHBDD2 | RHBDD3 | RHBDF1 | RHBDF2 | RHBDL1 | RHBDL2 | RHBDL3 | RHBG | RHCE | RHCG | RHD | RHEB